SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

S&P Global, Inc. engages in the provision of transparent and independent ratings, benchmarks, analytics, and data to the capital and commodity markets worldwide. It operates through the following segments: Market Intelligence, Ratings, Mobility, Indices, and Engineering Solutions. The Market Intelligence segment provides multi-asset-class data and analytics integrated with purpose-built workflow solutions. The Ratings segment is involved in credit ratings, research, and analytics, offering investors and other market participants information, ratings, and benchmarks. The Mobility segment offers solutions serving the full automotive value chain including vehicle manufacturers, automotive suppliers, mobility service providers, retailers, consumers, and finance and insurance companies. The Engineering Solutions segment engages in advanced knowledge discovery technologies, research tools, and software-based engineering decision engines to advance innovation, maximize productivity, improve quality, and reduce risk. The company was founded by James H. McGraw and John A. Hill in 1917 and is headquartered in New York, NY.

S&P Global Inc

S&P Global is facing heightened attention as investors weigh the potential impact of generative AI on its data and analytics moats, while simultaneously tracking the upcoming spinoff of its Mobility division. The market is actively scrutinizing the company's valuation against broader macro pressures and evolving competitive landscapes within financial information services.

CEVA, Inc. engages in the provision of silicon and software intellectual property solutions that enable smart edge products to connect, sense, and infer data. Its products include Ceva-Waves Links, Ceva-Waves Wi-Fi, Ceva-Waves Dragonfly, Ceva-XC23, Ceva-XC21, Ceva-Waves Bluetooth, Ceva-Waves UWB, Ceva-PentaG2, and Ceva-PentaG RAN. The company was founded on November 22, 1999 and is headquartered in Rockville, MD.

Ceva Inc.

Ceva Inc. is trending as investors focus on its role as a semiconductor IP provider for edge AI and wireless connectivity, with the community closely tracking its recent earnings performance and long-term design win momentum. Market participants are debating whether the stock serves as a strategic play on the expanding AI hardware stack or if it remains a cyclical laggard, while many discuss the potential upside tied to its diverse licensing royalty model.

Albany International Corp. engages in textiles and materials processing. It operates through the following segments: Machine Clothing and Albany Engineered Composites. The Machine Clothing segment supplies fabrics used in the manufacturing process in the pulp, corrugator, nonwovens, fiber cement, building products, and tannery and textile industries. The Engineered Composites segment provides composite structures to customers in the commercial and defense aerospace industries. The firm offers regular fabric, consultative, diagnostic, and project specific services. The company was founded on March 8, 1895 and is headquartered in Portsmouth, NH.

Albany International Corp. - Ordinary Shares - Class A

Albany International is gaining attention as investors weigh its dual exposure to industrial manufacturing and aerospace components, particularly amid ongoing discussions about its long-term defense contracts. The community is actively debating the company's valuation as analysts continue to adjust ratings and price targets ahead of upcoming earnings reports.

MACOM Technology Solutions Holdings, Inc. engages in designing, developing, manufacturing, and marketing semiconductors and modules. The firm is involved in the provision of products for telecommunications (Telecom), industrial and defense (I&D), and data center industries. The company was founded on March 25, 2009 and is headquartered in Lowell, MA.

MACOM Technology Solutions Holdings Inc

MACOM Technology Solutions is gaining traction as investors focus on its role in scaling AI infrastructure and its strategic pivot toward photonics and high-performance data center connectivity. While the stock has seen a significant year-to-date rally, community sentiment remains split between those emphasizing its long-term growth potential in AI and others expressing caution due to high valuation multiples.

Ethena

Ethena is seeing significant community attention driven by ongoing institutional accumulation and reports of major token buys from high-profile figures. While traders are actively debating its potential as a 'real yield' play and closely monitoring technical breakout patterns, discussions also highlight broader concerns regarding long-term token unlock pressure and market volatility.

Microchip Technology, Inc. engages in the provision of semiconductor products. It operates through the Semiconductor Products and Technology Licensing segments. The Semiconductor Products segment is involved in designing, developing, manufacturing, and marketing microcontrollers, development tools and analog, interface, mixed signal, connectivity devices, and timing products. The Technology Licensing segment offers license fees and royalties associated with technology licenses for the use of SuperFlash embedded flash and Smartbits one-time programmable technologies. The company was founded on February 14, 1989 and is headquartered in Chandler, AZ.

Microchip Technology, Inc.

Microchip Technology is attracting significant investor attention following its recent data center revenue growth, signaling a potential cyclical recovery and strengthening its position within the AI infrastructure supply chain. The community is actively debating whether to anchor capital in MCHP as a cash-flowing value play or to pursue higher-velocity growth opportunities elsewhere in the semiconductor sector.

Alto Ingredients, Inc. engages in the production and marketing of specialty alcohols and essential ingredients. It operates through the following segments: Marketing and Distribution, Pekin Production, and Western Production. The Marketing and Distribution segment includes marketing and merchant trading for company-produced alcohols and essential ingredients, on an aggregated basis, and third-party fuel-grade ethanol. The Pekin Campus Production segment deals with the production and sale of alcohols and essential ingredients produced at the company's Pekin, Illinois campus. The Western Production segment covers the production and sale of renewable fuel and essential ingredients produced at two western production facilities. The company was founded by William L. Jones and Neil M. Koehler on January 30, 2003 and is headquartered in Pekin, IL.

Alto Ingredients Inc

Alto Ingredients is seeing significant attention as activist investors push for strategic alternatives, including a potential sale or merger to unlock value from the company's core assets and carbon capture potential. Market participants are closely watching the impact of impending biofuels legislation and clean fuel tax credits, which the community believes could materially improve the company's long-term profitability.

ProShares Trust - PowerShares UltraShort Lehman 20+ Year Treasury ProShares 2x Shares

ProShares UltraShort 20+ Year Treasury ETF

TBT is gaining significant attention as investors react to a backdrop of rising Treasury yields and persistent inflation concerns, fueling a wave of speculative interest in leveraged inverse bond ETFs. The community is actively debating the sustainability of current bond market trends, with many traders closely monitoring Treasury auction data and shifting Federal Reserve policy expectations to gauge potential volatility.

Alpha & Omega Semiconductor Ltd. engages in the design, development and supply of power semiconductor products for computing, consumer electronics, communication, and industrial applications. It operates through the following geographical segments: Hong Kong, China, South Korea, United States, and Other Countries. The company was founded by Mike F. Chang, Yueh-Se Ho, Anup Bhalla, and Sik Kwong Lui on September 27, 2000 and is headquartered in Sunnyvale, CA.

Alpha & Omega Semiconductor Ltd

Alpha & Omega Semiconductor is gaining market attention as investors track its strategic role in next-generation 800V power architectures and AI data center infrastructure. The community is actively debating the company's valuation and long-term potential as it expands its partnerships within the semiconductor and power electronics ecosystem.

SK Telecom Co., Ltd. engages in the provision of telecommunication and internet services. It operates through the following business divisions: Wireless Communication, Wired Communication, and Other. The Wireless Communication division deals with mobile phones, wireless data, information, and communication business. The Wired Communication division provides phone, high-speed Internet, data, and communication network rental services. The Other division includes product sales-type data broadcasting channel use business. The company was founded on March 29, 1984 and is headquartered in Seoul, South Korea.

SK Telecom Co Ltd - ADR

SK Telecom Co. Ltd.

SK Telecom is trending as investors position for the company's significant indirect exposure to the AI sector, specifically through its high-value stake in Anthropic. The community is actively discussing its potential as a strategic 'backdoor' play on physical AI and robotics, further bolstered by partnerships with industry leaders like Nvidia.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026

Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026 Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business...

Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results

Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results PR Newswire CARMIEL, Israel, March...

Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026

Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026 Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business...

PLX Shares Jump 13% On EMA Committee’s Turnaround On New Dosing Regimen For Fabry Disease Therapy

Equity

The Committee for Medicinal Products for Human Use recommended approval of the 2mg/kg every-4-weeks dosing regimen in Fabry disease adult patients.


PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. (Protalix or the Company) (NYSE...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Protalix BioTherapeutics Stock Tumbled 28% Today: Why The Latest CHMP Opinion Is Sparking Concerns Among Investors?

However, Protalix CEO said that the results of the review do not change the priority of the company to reduce treatment burden for patients with Fabry disease.

Regulus Downgraded By Analysts After $1.7B Novartis Buyout Offer — Street Sees Limited Upside Ahead

Regulus Therapeutics shares surged after Novartis announced a $1.7 billion acquisition, but analysts downgraded the stock citing limited upside. Retail sentiment remained bullish, with speculation of a higher bid or FDA-driven gains.

Pluxee shares jump 11% on strong Q1 operating revenue growth

Investing.com -- Pluxee NV (EPA:PLX) reported 12.1% organic growth in first-quarter operating revenue, beating market expectations, and sending its shares soaring 11% in European trading Wednesday.

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

PLXProtalix BioTherapeutics Inc.

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest PLX News